Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/10385
Title: | Treatment Planning System Commissioning of the Eclipse PBC Dose Calculation Algorithm for the Varian Clinac iX S/N 5052 | Authors: | Lukarski, Dushko Nikolovski, Dragan |
Keywords: | TPS commissioning PBC algorithm Eclipse TPS |
Issue Date: | 19-Oct-2013 | Publisher: | Association for Medical Physics and Biomedical Engineering | Conference: | Third Conference on Medical Physics and Biomedical Engineering, Skopje, R. Macedonia | Abstract: | The commissioning of the Treatment Planning System (TPS) is an important part of the commissioning of a new linear accelerator (linac). In this work, we evaluated the performance of the Pencil Beam Convolution (PBC) algorithm configured for the new Varian Clinac iX (S/N 5052) at the University Clinic of Radiotherapy and Oncology in Skopje. The evaluation was performed in two stages. In the first stage, we used a workspace of the TPS itself, called “Beam Analysis”, in which the system itself calculates the depth dose and profile curves for a water phantom and compares them with those measured during the commissioning of the accelerator. In the second stage, we created, calculated and irradiated 9 test plans on a polystyrene phantom “OPERA” and measured the dose in a point with a system for absolute dosimetry and then compared the measurements with the calculations. In both stages, the results of the comparison were below 3%, in most clinically relevant cases below 2%, which indicates that the PBC algorithm can safely be commissioned for clinical use. | URI: | http://hdl.handle.net/20.500.12188/10385 | ISBN: | 978-608-65213-1-8 |
Appears in Collections: | Faculty of Medicine: Conference papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Lukarski_ThirdConference pg.33.pdf | 329.49 kB | Adobe PDF | View/Open |
Page view(s)
62
checked on Jul 24, 2024
Download(s)
97
checked on Jul 24, 2024
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.